Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Chip-Highflyer Hua Hong: Nvidia sorgt für Kurssturz (Der Aktionaer) +++ HUA HONG Aktie -5,25%

INNOVENT BIOLOGICS Aktie

 >INNOVENT BIO Aktienkurs 
10.616 EUR    -5.5%    (TradegateBSX)
Ask: 10.834 EUR / 900 Stück
Bid: 10.564 EUR / 900 Stück
Tagesumsatz: 100 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
INNOVENT BIO Aktie über LYNX handeln
>INNOVENT BIO Performance
1 Woche: +3,1%
1 Monat: +0,1%
3 Monate: +29,2%
6 Monate: +25,5%
1 Jahr: +8,0%
laufendes Jahr: +29,1%
>INNOVENT BIOLOGICS Aktie
Name:  INNOVENT BIOLOGICS INC.
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  KYG4818G1010 / A2N7N8
Symbol/ Ticker:  6IB (Frankfurt)
Kürzel:  FRA:6IB, ETR:6IB, 6IB:GR
Index:  -
Webseite:  https://en.innoventbio.co..
Profil:  Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmaceutical and biotechnology company based in China, ..
>Volltext..
Marktkapitalisierung:  19466.28 Mio. EUR
Unternehmenswert:  17188.66 Mio. EUR
Umsatz:  1967.68 Mio. EUR
EBITDA:  415.95 Mio. EUR
Nettogewinn:  157.31 Mio. EUR
Gewinn je Aktie:  0.09 EUR
Schulden:  300.45 Mio. EUR
Liquide Mittel:  2247.73 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  2.15
Umsatzwachstum:  47.26%
Gewinnwachstum:  19.02%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  INNOVENT BIOLOGICS, INNOVENT BIO
Letzte Datenerhebung:  28.09.26
>INNOVENT BIO Kennzahlen
Aktien/ Unternehmen:
Aktien: 1744.85 Mio. St.
Frei handelbar: 89.84%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 7502
Umsatz/Mitarb.: 0.21 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 24.72%
Bewertung:
KGV: 134.17
KGV lG: 65.07
KUV: 9.87
KBV: -
PEG-Ratio: 16.65
EV/EBITDA: 41.32
Rentabilität:
Bruttomarge: 85.85%
Gewinnmarge: 7.99%
Operative Marge: 16.9%
Managementeffizenz:
Gesamtkaprendite: 3.8%
Eigenkaprendite: 7.07%
>INNOVENT BIO Peer Group
Gesundheit, Stoffwechselerkrankungen (Diabetes/ Adipositas), Autoimmunerkrankungen, Onkologie/ Krebs- Behandlung
 
28.09.26 - 02:03
 Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC (PR Newswire)
 
SAN FRANCISCO and SUZHOU, China, Sept. 27, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology,......
25.09.26 - 10:45
 Research: HSBC Research: 2026 to Be Harvest Yr for CN Innovative Drug Out-Licensing; Buy Kept on HANSOH PHARMA, SKB BIO, INNOVENT BIO, AKESO and KEYMED BIO-B (AAStocks)
 
Despite mounting US interest rates, China's biopharmaceutical sector remained resilient in late September across the Hong Kong and mainland China markets, supported by policy measures and prospects for out-licensing, HSBC Global Investment Research said in a report.2026 will be a harvest year for China's innovative drug ......
23.09.26 - 10:51
 Innovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting (PR Newswire)
 
SAN FRANCISCO and SUZHOU, China, Sept. 23, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic,......
14.09.26 - 15:00
 Health Care Roundup: Market Talk (WSJ EN)
 
Find insight on Innovent Biologics, AstraZeneca, Sumitomo Pharma and more in the latest Market Talks covering Health Care....
09.09.26 - 09:15
 Research: HSBC Research: Healthcare Sector Supported by Resilient Demand, Favors INNOVENT BIO , SKB BIO , WUXI APPTEC (AAStocks)
 
HSBC Global Investment Research published a research report stating that it recently communicated with management teams of 18 healthcare companies during investor events and believes the sector is currently supported by resilient demand. Since Jul 1, healthcare stocks have Outperformed the broader market, with the H-share health......
04.09.26 - 07:45
 Research: CLSA: China Biotech Fundamentals Remain Solid; Top Picks BEONE MEDICINES , INNOVENT BIO and LEADS BIOLABS-B (AAStocks)
 
CLSA issued a report stating that the fundamentals of China's biotechnology sector remain solid, supported by strong interim results, sustained momentum in out-licensing deals, and encouraging clinical data readouts. However, sector sentiment has yet to fully reflect the fundamental improvements. The broker believes the disconne......
28.08.26 - 08:45
 Research: CMSI Raises INNOVENT BIO TP to HKD122, Long-term Earnings Growth Outlook Supports Valuation (AAStocks)
 
China Merchants Securities (HK) issued a research report stating that INNOVENT BIO (01801.HK)'s total revenue in the first half of the year increased 56.7% YoY, in line with expectations. The SG&A expense ratio fell by 4 ppts, while the R&D expense ratio rose by 2.6 ppts, reflecting stringent control over overall selling and adm......
27.08.26 - 13:54
 Health Care Roundup: Market Talk (WSJ EN)
 
Find insight on Novo Nordisk, Innovent Biologics, Ramsay Health Care and more in the latest Market Talks covering Health Care....
27.08.26 - 07:15
 Research: Jefferies Adds INNOVENT BIO TP to HKD125, Maintains Buy Rating (AAStocks)
 
Jefferies issued a report on INNOVENT BIO (01801.HK), which recorded strong sales in 1H26, with improving profitability. The broker maintained its Buy rating and raised the TP from HKD105 to HKD125.Management was confident in achieving its 2027 product sales target of RMB20 billion, and proposed a 2030 revenue target of RMB35-40......
27.08.26 - 06:15
 Research: Daiwa Lifts INNOVENT BIO TP to HKD135; Revenue Guidance Is Major Positive (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
27.08.26 - 06:00
 Research: Citi Raises INNOVENT BIO TP to HKD149.6; 1H Results Beat; FY2030 Revenue Guidance Forecast to be Met (AAStocks)
 
Citi issued a report covering INNOVENT BIO (01801.HK), of which total revenue for 1H reached RMB8.62 billion, up 45% YoY, and net profit grew 50% YoY to RMB1.25 billion, both topping the broker's and market's expectations.The report noted that management proposed FY2030 revenue guidance of RMB35-40 billion, and expected ......
26.08.26 - 11:00
 H Shrs: HSI Adds 141 Pts for Day; INNOVENT BIO, ANTA SPORTS Jump 9%+ Post-results; BABA-W Rebounds 2% (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
26.08.26 - 10:30
 Full-day Takeaway: HSI Closes at 25,652, Up 141 pts; HSTI Closes at 4,626, Up 37 pts; INNOVENT BIO Up over 9%; INNOVENT BIO, H&H INTL HLDG, GENSCRIPT BIO Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 141 pts or 0.6% to 25,652. HSTI rose 37 pts or 0.8% to 4,626. HSCEI gained 88 pts or 1.0% to 8,533. Market turnover reached $254.82 billion.Active Heavyweights:XIAOMI (01810.HK) closed at $28.46, up 2.5%PING AN (02318.HK) closed at $57.65, up 2.2%BABA (09988.HK) closed at $116.6, up 2.1%MEITUAN (03690.HK) clos......
26.08.26 - 09:18
 Starke Halbjahreszahlen katapultieren Innovent Biologics Aktie auf Rekordhoch (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
26.08.26 - 07:45
 INNOVENT BIO Spikes 8%+ as Results Beat; G Sachs and CLSA Raise TPs (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
26.08.26 - 07:00
 H Shrs: HSI Gains 174 Pts at Half-day; XIAOMI-W Up 4%; INNOVENT BIO Swells 8%+ Post-results; SHENZHOU INTL Dives 7%+ (AAStocks)
 
This morning (26th), the HSI opened up 124 pts and closed the half-day session at 25,685, up 174 pts or 0.68%, with market turnover at HKD139.917 billion. The HSCEI concluded at 8,549, up 104 pts or 1.23%, while the HSTECH finished at 4,660, up 72 pts or 1.58%.Major tech stocks were broadly higher. BABA-W (09988.HK) grew 1.49% a......
26.08.26 - 04:00
 INNOVENT BIO Surges ~10% in Early Trade as Interim Product Revenue Jumps 56.7% (AAStocks)
 
INNOVENT BIO (01801.HK) opened at HKD106.6 today (26th), up nearly 6.5%. With the gain widened in early trading, the stock last reported at HKD110, up 9.89%, on turnover of 2.9071 million shares involving HKD316 million.INNOVENT BIO announced its interim results for the period ended June. Revenue rose nearly 45% YoY to RMB8.618 ......
25.08.26 - 21:57
 Innovent Biologics reports 1H results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
25.08.26 - 12:30
 Results: INNOVENT BIO Interim Net Profit Up 50.2% to RMB1.25B (AAStocks)
 
INNOVENT BIO (01801.HK) announced its interim results for the six months ended June 2026. Total revenue mounted 44.8% YoY to RMB8.618 billion. Profit for the period climbed 50.2% YoY to RMB1.253 billion. EPS was RMB0.73. Non-IFRS profit during the period grew 40.5% to RMB1.703 billion.During the period, gross profit lifted 43% t......
25.08.26 - 12:18
 Innovent Announces 2026 Interim Results and Business Updates (PR Newswire)
 
Transforming from Regional Leader to Global Premier: A Clear Strategic Path for Growth and Globalization SAN FRANCISCO and SUZHOU, China, Aug. 25, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Respekt vor den Fakten. Gefühl für das Wichtige. Kraft zur Unabhängigkeit. - Nomen Nescio
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!